IT Press Releases
SEE OTHER BRANDS

Get your fresh news on information technology in the world

IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on April 30, 2025

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

RAMSEY, N.J. and BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing …

The Chefs’ Warehouse Reports First Quarter 2025 Financial Results

The Chefs’ Warehouse Reports First Quarter 2025 Financial Results

RIDGEFIELD, Conn., April 30, 2025 (GLOBE NEWSWIRE) -- The Chefs’ Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs’”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial …

Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025

Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …

Chicago Atlantic BDC, Inc. Announces First Quarter 2025 Financial Results Conference Call

Chicago Atlantic BDC, Inc. Announces First Quarter 2025 Financial Results Conference Call

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its financial …

Larimar Therapeutics Reports First Quarter 2025 Financial Results

Larimar Therapeutics Reports First Quarter 2025 Financial Results

FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval planned to be submitted by year-end …

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025

ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that an abstract for …

ScottsMiracle-Gro Reports Second Quarter Results; Gross Margin Improvement Drives EBITDA Growth

ScottsMiracle-Gro Reports Second Quarter Results; Gross Margin Improvement Drives EBITDA Growth

Company reaffirms full-year U.S. Consumer segment net sales, consolidated adjusted gross margin and adjusted EBITDA and free cash flow guidance Consumer POS units were up 12 percent through first half; 60 percent of full-year consumer takeaway expected in …

XORTX Provides Update on FDA Type B Meeting Request

XORTX Provides Update on FDA Type B Meeting Request

● XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical …

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results

WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 …

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025

POMPANO BEACH, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it …

SunPower Reports Q1’25: $80.2M Revenue, $1.3M Profit¹

SunPower Reports Q1’25: $80.2M Revenue, $1.3M Profit¹

OREM, Utah, April 30, 2025 (GLOBE NEWSWIRE) -- SunPower, formerly d/b/a Complete Solaria, Inc. (“SunPower” or the “Company”) (Nasdaq: SPWR), a solar technology, services, and installation company, will present its 2024 and Q1’25 results via webcast at 1: …

OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain

Urcosimod phase 2 trial treating Neuropathic Corneal Pain (“NCP”) patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial. OKYO Pharma plans to analyze the efficacy data from the 17 patients who …

Wabash Announces First Quarter 2025 Results

Wabash Announces First Quarter 2025 Results

Quarterly revenue of $381 million - lower than prior quarterly outlook range on weaker Transportation Solutions demand. Parts …

CLIQ: Einladung zum Earnings Call für das erste Quartal 2025

CLIQ: Einladung zum Earnings Call für das erste Quartal 2025

DÜSSELDORF, 30. April 2025 – Der CLIQ-Konzern wird am Donnerstag, den 8. Mai 2025, seine Finanzergebnisse und Highlights für das erste Quartal 2025 präsentieren. Der Finanzbericht Q1 2025 und die begleitende Präsentation zum Earnings Call werden ab 7:30 …

CLIQ: Invitation to First Quarter 2025 Results Presentation

CLIQ: Invitation to First Quarter 2025 Results Presentation

DÜSSELDORF, 30 April 2025 – The CLIQ Group will report and present its first quarter 2025 financial results and highlights on Thursday, 8 May 2025. The 1Q 2025 Financial Report and a slides deck to accompany the earnings call will be available at https:// …

Banco Itaú Chile Announces First Quarter 2025 Management Discussion & Analysis Report

Banco Itaú Chile Announces First Quarter 2025 Management Discussion & Analysis Report

SANTIAGO, Chile, April 30, 2025 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (SSE: ITAUCL) announced today its Management Discussion …

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate

New high-quality cell growth supplement for cell manufacturing applications including in regenerative medicine and cell therapies Human Platelet Lysate (HPL) offers a safer and sustainable alternative to Fetal Bovine/ Calf Serum (FBS/FCS) Gamma-irradiated …

Cority Launches Advanced Motion Capture Solution to Strengthen Industrial Ergonomics Programs

Cority Launches Advanced Motion Capture Solution to Strengthen Industrial Ergonomics Programs

TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Cority, the global leader in enterprise Environmental, Health, and Safety (EHS) and Sustainability software, today announced the release of its new AI-powered Motion Capture for Industrial Ergonomics solution. …

KE Holdings Inc. to Report First Quarter 2025 Financial Results on May 15, 2025 Eastern Time

KE Holdings Inc. to Report First Quarter 2025 Financial Results on May 15, 2025 Eastern Time

BEIJING, April 30, 2025 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that it will report its unaudited …

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

ATHENS, Greece and LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, today announced that it has signed an agreement with Puma …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service